MatthewOliverMD

Gynecologic Oncology

Physician

Dr. Oliver is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 Dudley St
Program In Women's Oncology
Providence, RI 02905
Phone+1 401-274-1122

HCA Healthcare/Mercer University School of Medicine/Memorial Health University Medical CenterResidency, Obstetrics and Gynecology, 2011 - 2015
East Tennessee State University James H. Quillen College of MedicineClass of 2011

PubMed

3 citations
Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer.
Sebastian Z Ramos, Amita Kulkarni, Matthew Oliver, Valery A Danilack, Cara Mathews
International Journal of Gynecological Cancer. 2023-01-03
19 citations
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
Nicole E. James, Jenna B. Emerson, Ashley D. Borgstadt, Lindsey Beffa, Matthew T. Oliver
Scientific Reports. 2020-05-22
21 citations
Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes.
Nicole E. James, Lindsey Beffa, Matthew T. Oliver, Ashley D. Borgstadt, Jenna B. Emerson
Oncotarget. 2019-05-21

Study: COVID-19 Vaccines Protect Adults on Dialysis Against Infection, Severe DiseaseMarch 9th, 2022
New Study to Assess COVID-19 Vaccine Effectiveness Among People Living with Chronic Kidney DiseaseSeptember 2nd, 2021
Dr. Whitney Joins Memorial Primary Care Unit in Cleveland and More Chattanooga-Area Career MovesJune 12th, 2021
Join now to see all